mifepristone has been researched along with decitabine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bayatti, N; Behl, C; Clement, AM; Engele, J; Figiel, M; Witan, H; Zschocke, J | 1 |
| Fernandez, SV; Giulianelli, S; Goin, M; Lanari, C; Russo, J; Wargon, V | 1 |
| Mjoli, PB; Poolman, T; Ray, DW; Singh, N; Sommer, P; Taylor, K | 1 |
1 review(s) available for mifepristone and decitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for mifepristone and decitabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions.
Topics: Adrenal Cortex Hormones; Amino Acid Transport System X-AG; Animals; Astrocytes; Azacitidine; Blotting, Western; Brain; Central Nervous System; Cerebellum; Corticosterone; Decitabine; Detergents; Dexamethasone; DNA Methylation; DNA Modification Methylases; DNA Primers; Dose-Response Relationship, Drug; Fluorescent Dyes; Glucocorticoids; Immunohistochemistry; Kainic Acid; Ligands; Luciferases; Membrane Microdomains; Mifepristone; Neuroglia; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Up-Regulation | 2005 |
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Topics: Animals; Apoptosis; Azacitidine; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Decitabine; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Hormone Antagonists; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mifepristone; Mitosis; Neoplasm Transplantation; Promoter Regions, Genetic; Receptors, Glucocorticoid; Receptors, Progesterone; Transplantation, Heterologous; Tumor Burden | 2011 |
The N-terminal transactivation domain of the glucocorticoid receptor mediates apoptosis of human small cell lung cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Humans; Lung Neoplasms; Mifepristone; Promoter Regions, Genetic; Protein Structure, Tertiary; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Transcriptional Activation | 2014 |